Abstract
A series of sixteen benzoyl thiourea derivatives was prepared in good to excellent yield (49–92 %). Eight out of sixteen were reported compounds. The structures of prepared derivatives were elucidated by Fourier transform infrared spectroscopy (FTIR), proton nuclear magnetic (1H NMR) and carbon nuclear magnetic resonance (13C NMR), and mass spectroscopy (ESI-MS). The structure of two compounds TU-8 and TU-15 was further established by single crystal X-ray diffraction (SCXRD) studies. All of the prepared compounds were screened for their potential as α-glucosidase inhibitor and found to be more potent than standard acarbose. TU-8 and TU-14 were lead compounds with IC50 values 1.59 ± 0.04 µM and 0.60 ± 0.02 µM, respectively. All the prepared compounds were found to non-toxic to fibroblast 3T3-L1 cell lines. The structure activity relation was confirmed by various substituents on phenyl ring. Furthermore, the interaction of compounds with enzyme was confirmed by docking studies. This study proves that synthesized 1, 3-disubstituted thiourea derivatives are excellent α-glucosidase inhibitor and can be exploited to design novel therapeutics to cure type-II diabetes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.